Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,740
Total Claims
$679K
Drug Cost
426
Beneficiaries
$1,593
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-88%
Opioid rate vs peers
0.3% vs 2.6% avg
+49%
Cost per patient vs peers
$1,593 vs $1,068 avg
+17%
Brand preference vs peers
10.5% vs 9.0% avg
Opioid Prescribing
0.3%
Opioid Rate
30
Opioid Claims
$512
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,009 claims · $502K
Generic: 8,602 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 47 | $50K |
| Apixaban | 45 | $33K |
| Rivaroxaban | 27 | $24K |
| Sitagliptin Phosphate | 25 | $21K |
| Budesonide/Formoterol Fumarate | 42 | $19K |
| Insulin Aspart | 20 | $17K |
| Fluticasone/Umeclidin/Vilanter | 24 | $17K |
| Dulaglutide | 16 | $16K |
| Insulin Detemir | 17 | $13K |
| Insulin Detemir | 13 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $13K |
| Insulin Nph Hum/Reg Insulin Hm | 12 | $9,298 |
| Insulin Degludec | 16 | $9,217 |
| Linaclotide | 15 | $8,286 |
| Levothyroxine Sodium | 324 | $6,659 |
Prescribing Profile
Patient Profile
70
Avg Age
56%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data